Serum Protein Profiling of Smear-Positive and Smear-Negative Pulmonary Tuberculosis Using SELDI-TOF Mass Spectrometry

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Lung

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00408-009-9199-6PMID 20012079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a clinical scoring system for the diagnosis of smear-negative pulmonary tuberculosis.

  2008cited by this paper
• Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data

  2008cited by this paper
• Performance of Purified Antigens for Serodiagnosis of Pulmonary Tuberculosis: a Meta-Analysis

  2008cited by this paper
• Serodiagnosis of tuberculosis: specific detection of free and complex-dissociated antibodies anti-mycobacterium tuberculosis recombinant antigens.

  2008cited by this paper
• Progress in Serodiagnosis of Mycobacterium tuberculosis Infection

  2007cited by this paper
• Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis.

  2007cited by this paper
• Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system

  2007cited by this paper
• Interferonγ/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis

  2007cited by this paper
• The 6-Kilodalton Early Secreted Antigenic Target-Responsive, Asymptomatic Contacts of Tuberculosis Patients Express Elevated Levels of Interleukin-4 and Reduced Levels of Gamma Interferon

  2006cited by this paper
• Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum

  2006cited by this paper
• The blood peptidome: a higher dimension of information content for cancer biomarker discovery

  2006cited by this paper
• A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.

  2005cited by this paper
• Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.

  2005cited by this paper
• Lessons from controversy: ovarian cancer screening and serum proteomics.

  2005cited by this paper
• Proteomic Fingerprints for Potential Application to Early Diagnosis of Severe Acute Respiratory Syndrome

  2005cited by this paper
• Serum Protein Profiles to Identify Head and Neck Cancer

  2004cited by this paper
• A novel and accurate diagnostic test for human African trypanosomiasis.

  2004cited by this paper
• Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments

  2004cited by this paper
• Current developments in SELDI affinity technology.

  2004cited by this paper
• Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

  2003cited by this paper
• Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons

  2003cited by this paper
• Diagnosis of tuberculosis: Available technologies, limitations, and possibilities

  2003cited by this paper
• Putative protein markers in the sera of men with prostatic neoplasms

  2003cited by this paper
• Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry.

  2003cited by this paper
• Clinical proteomics: Written in blood

  2003cited by this paper
• Current achievements using ProteinChip Array technology.

  2002cited by this paper
• Identifying pulmonary tuberculosis in patients with negative sputum smear results.

  2001cited by this paper
• Revised international definitions in tuberculosis control.

  2001cited by this paper
• Tuberculosis Contacts but Not Patients Have Higher Gamma Interferon Responses to ESAT-6 than Do Community Controls in The Gambia

  2001cited by this paper
• Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment1

  2001cited by this paper
• A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis.

  2000cited by this paper
• Recent advancements in surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry

  2000cited by this paper
• Treatment of tuberculosis: guidelines for national programmes. Second edition.

  1997cited by this paper
• T-cell cytokine responses in human infection with Mycobacterium tuberculosis

  1995cited by this paper

• Innovative electrochemical biosensors for tuberculosis detection.

  2025cites this paper
• Proteomics-based host-specific biomarkers for tuberculosis: The future of TB diagnosis.

  2024cites this paper
• From simple to complex: Protein‐based biomarker discovery in tuberculosis

  2023cites this paper
• Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism

  2023cites this paper
• New technologies for diagnosing active TB: the VANTDET diagnostic accuracy study

  2021cites this paper
• Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa

  2021cites this paper
• Use of Blood, Urine or Saliva-based Biomarkers in the Diagnosis of Active Pulmonary Tuberculosis-Sample Type Matters

  2021cites this paper
• Conventional and Molecular Diagnosis of Drug-Sensitive and Drug-Resistant Pulmonary Tuberculosis

  2018cites this paper
• Quantum dots in proteomic studies and medical diagnostics

  2018cites this paper
• An overview on the Current Status of Tuberculosis and its Biomarkers

  2017cites this paper
• Clinical MALDI mass spectrometry for tuberculosis diagnostics: speculating the methodological blueprint and contemplating the obligation to improvise

  2017cites this paper
• Proteomics and Host–Pathogen Interactions

  2017cites this paper
• Diagnostic ‘omics’ for active tuberculosis

  2016cites this paper
• Tuberculosis Biomarkers: From Diagnosis to Protection

  2016cites this paper
• A review of clinical models for the evaluation of human TB vaccines

  2016cites this paper
• A new era in the control of tuberculosis

  2016cites this paper
• Proteome analysis of the macroscopically affected colonic mucosa of Crohn’s disease and intestinal tuberculosis

  2016cites this paper
• Comparative proteomic analysis of serum diagnosis patterns of sputum smear-positive pulmonary tuberculosis based on magnetic bead separation and mass spectrometry analysis.

  2015cites this paper
• Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals

  2015cites this paper
• Clinical immunology and multiplex biomarkers of human tuberculosis.

  2015cites this paper
• Discovery and verification of serum differential expression proteins for pulmonary tuberculosis.

  2015cites this paper
• Identification of Biomarkers of Infectious Disease Using Surface-Enhanced Laser Desorption/Ionisation Mass Spectrometry

  2013cites this paper
• The discovery and identification of a candidate proteomic biomarker of active tuberculosis

  2013cites this paper
• Biomarkers of tuberculosis: a research roadmap.

  2013cites this paper
• Processing of Mass Spectrometry Data in Clinical Applications

  2012cites this paper
• STATE OF THE ART SERIES New Tools, Series editor: Wing-Wai Yew NUMBER 3 IN THE SERIES Enabling biomarkers for tuberculosis control

  2012cites this paper
• New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

  2011cites this paper
• Proteomic progress in studying tuberculosis from 2010 to 2011

  2011cites this paper
• Exploring Serological Classification Tree Model of Active Pulmonary Tuberculosis by Magnetic Beads Pretreatment and MALDI‐TOF MS Analysis

  2011cites this paper
• Establishing a serologic decision tree model of extrapulmonary tuberculosis by MALDI-TOF MS analysis.

  2011cites this paper
• Immunological biomarkers of tuberculosis

  2011cites this paper
• Proteomics and Host—Pathogen Interactions

  2010cites this paper